CMRA - Comera Life Sciences GAAP EPS of -$0.20 revenue of $235M November, 10 2022 09:32 AM Comera Life Sciences Holdings Inc. Comera Life Sciences press release ( NASDAQ: CMRA ): Q3 GAAP EPS of -$0.20. Revenue of $235M (+167.0% Y/Y). For further details see: Comera Life Sciences GAAP EPS of -$0.20, revenue of $235M